138
B.-S. Chai et al. / Chinese Chemical Letters 25 (2014) 137–140
intermediate derivatisation method
Cl
Cl
NH
O
NH
O
NH
O
N
N
O
O
optimisation
N
N
O
O
N
N
O
O
O
F3C
O
F3C
O
Lead compound
Secondary lead compound
Fig. 1. The discovery of pyriminostrobin.
pyriminostrobin
solution was cooled and then filtered. The solid was washed with
toluene and dried as intermediate 5.
7c: White solid. 1H NMR (300 MHz, CDCl3): 8.40 (s, 1H, Ph0-
d
NH-Py), 7.58 (s, 1H, C55CH), 7.55 (m, 2H, Ph0-2,6-2H), 7.50 (m,
1H, Ph-6-H), 7.37 (m, 2H, Ph-3,5-2H), 7.31 (m, 2H, Ph0-3,5-2H),
7.20 (m, H, Ph-4-H), 7.00 (s, 1H, Py-5-H), 5.40 (s, 2H, PhCH2O),
3.80 (s, 3H, COOCH3), 3.68 (s, 3H, 55C–OCH3); Mol. wt: 477.41.
LC–MS: m/z 476.5 [MꢀH]ꢀ, 478.4 [M+H]+, Anal. calcd. (%) for
Synthesis of (E)-methyl 2-(2-(((2-((2,4-difluorophenyl)amino)-6-
(trifluoromethyl)pyrimidin-4-yl)oxy)methyl)phenyl)-3-methoxya-
crylate (7e): A mixture of 2-((2,4-difluorophenyl)amino)-6-(tri-
fluoromethyl)pyrimidin-4(3H)-one (5e) (0.35 g, 1.2 mmol), (E)-
methyl 2-(2-(chloromethyl)phenyl)-3-methoxyacrylate (6) (0.30 g,
1.25 mmol) and K2CO3 (0.33 g, 2.4 mmol) in DMF (15 mL) was stirred
and heated at 80 8C for 8 h. The reaction mixture was then cooled,
diluted with water (100 mL), and extracted with ethyl acetate
(3 ꢁ 25 mL). The organic layer was separated, washed with saturated
brine, dried over MgSO4, and filtered. The filtrate was evaporated, and
the crude product was purified via silica gel column chromatography
using a 1:10 (v/v) mixture of ethyl acetate and petroleum ether
(boiling point range: 60–90 8C) as the eluent to obtain 0.44 g of white
C
23H19F4N3O4: C, 57.86; H, 4.01; N, 8.80; Found: C, 57.79; H,
4.00; N, 8.82.
7d: White solid. 1H NMR (300 MHz, CDCl3):
d
7.82 (s, 1H, Ph0-
NH-Py), 7.61 (s, 1H, C55CH), 7.48–7.06 (m, 7H, Ph0-3H + Ph-4H),
6.53 (s, 1H, Py-5-H), 5.34 (s, 2H, PhCH2O), 3.82 (s, 3H, COOCH3),
3.73 (s, 3H, 55C–OCH3); Mol. wt: 477.41. LC–MS: m/z 476.5
[MꢀH]ꢀ, 478.4 [M+H]+, Anal. calcd. (%) for C23H19F4N3O4: C, 57.86;
H, 4.01; N, 8.80; Found: C, 57.80; H, 4.02; N, 8.82.
7f: White solid. 1H NMR (300 MHz, CDCl3):
d
8.37 (s, 1H, Ph0-
crystals. 1H NMR (300 MHz, CDCl3):
d
8.28 (s, 1H, Ph0-NH-Py), 7.59 (s,
NH-Py), 7.59 (s, 1H, C55CH), 7.50–7.12 (m, 7H, Ph0-3H + Ph-4H),
6.56 (s, 1H, Py-5-H), 5.33 (s, 2H, PhCH2O), 3.80 (s, 3H, COOCH3),
3.70 (s, 3H, 55C–OCH3); Mol. wt: 511.85. LC–MS: m/z 510.7
[MꢀH]ꢀ, 512.8 [M+H]+, Anal. calcd. (%) for C23H18ClF4N3O4: C,
53.97; H, 3.54; N, 8.21; Found: C, 53.91; H, 3.55; N, 8.21.
1H, C55CH), 7.48–6.90 (m, 7H, Ph0-3H + Ph-4H), 6.54 (s, 1H, Py-5-H),
5.31 (s, 2H, PhCH2O), 3.80 (s, 3H, COOCH3), 3.70 (s, 3H, 55C–OCH3);
Mol. wt: 495.40. LC–MS: m/z 494.2 [MꢀH]ꢀ, 496.3 [M+H]+, Anal.
calcd. (%) for C23H18F5N3O4: C, 55.76; H, 3.66; N, 8.48; Found: C, 55.78;
H, 3.66; N, 8.52.
7g: White solid. 1H NMR (300 MHz, CDCl3):
d
8.06 (s, 1H, Ph0-
7a: White solid. 1H NMR (300 MHz, CDCl3):
d
7.86 (s, 1H, Ph0-
NH-Py), 7.81–7.18 (m, 9H, Ph0-4H + Ph-4H + C55CH), 6.53 (s, 1H,
Py-5-H), 5.30 (s, 2H, PhCH2O), 3.80 (s, 3H, COOCH3), 3.73 (s, 3H,
55C–OCH3); Mol. wt: 511.85. LC–MS: m/z 510.7 [MꢀH]ꢀ, 512.8
[M+H]+, Anal. calcd. (%) for C23H18–ClF4N3O4: C, 53.97; H, 3.54; N,
8.21; Found: C, 53.92; H, 3.50; N, 8.18.
NH-Py), 7.78 (d, 2H, Ph0-2,6-2H, J = 9.0 Hz), 7.62 (s, 1H, C55CH), 7.57
(d, 2H, Ph0-3,5-2H, J = 9.0 Hz), 7.48 (m, 1H, Ph-6-H), 7.35 (m, 2H,
Ph-3,5-2H), 7.20 (m, 1H, Ph-4-H), 6.57 (s, 1H, Py-5-H), 5.35 (s, 2H,
PhCH2O), 3.81 (s, 3H, COOCH3), 3.74 (s, 3H, 55C–OCH3); Mol. wt:
527.42. LC–MS: m/z 526.5 [MꢀH]ꢀ, 528.3 [M+H]+, Anal. calcd. (%)
for C24H19F6N3O4: C, 54.65; H, 3.63; N, 7.97; Found: C, 54.69; H,
3.66; N, 7.98.
7h: White solid. 1H NMR (300 MHz, CDCl3):
d 7.54 (s, 1H,
C55CH), 7.00–7.33 (m, 7H, Ph0-3H + Ph-4H), 6.71 (br s, 1H, Ph0-NH-
Py), 6.48 (s, 1H, Py-5-H), 5.16 (s, 2H, PhCH2O), 3.75 (s, 3H, COOCH3),
3.67 (s, 3H, 55C–OCH3); Mol. wt: 495.40. LC–MS: m/z 494.2
[MꢀH]ꢀ, 496.3 [M+H]+, Anal. calcd. (%) for C23H18F5N3O4: C, 55.76;
H, 3.66; N, 8.48; Found: C, 55.78; H, 3.68; N, 8.50.
7b: White solid. 1H NMR (300 MHz, CDCl3): 8.06 (br s, 1H, Ph0-
d
NH-Py), 7.81–7.18 (m, 9H, Ph0-4H + Ph-4H + C55CH), 6.53 (s, 1H,
Py-5-H), 5.30 (s, 2H, PhCH2O), 3.80 (s, 3H, COOCH3), 3.73 (s, 3H,
55C–OCH3); Mol. wt: 527.42. LC–MS: m/z 526.5 [MꢀH]ꢀ, 528.3
[M+H]+, Anal. calcd. (%) for C24H19F6N3O4: C, 54.65; H, 3.63; N,
7.97; Found: C, 54.66; H, 3.65; N, 7.98.
7i: White solid. 1H NMR (300 MHz, CDCl3): 8.06 (br s, 1H, Ph0-
d
NH-Py), 7.59 (s, 1H, C55CH), 7.48–6.98 (m, 6H, Ph0-2H + Ph-4H),
6.57 (s, 1H, Py-5-H), 5.31 (s, 2H, PhCH2O), 3.81 (s, 3H, COOCH3),
O
H
NH
N
2
NH
2
a
O
O
1
1
R
R
NH
Cl
1/2 H CO
2
1
3
CF
R
3
1
2
2
R
NH
O
c
6
N
1
R
O
O
N
N
O
d
O
N
H
N
H
O
F C
O
3
F C
O
3
3
5
2
b
R
O
O
7
F C
3
O
CH
3
4
Scheme 1. Synthetic route of title compounds 7: (a) NH2CN, HCl, 85 8C; (b) CH3Br, NaH, DMF; (c) toluene, reflux; and (d) K2CO3, DMF, 80 8C.